AR018402A1 - DERIVADO DE PIRAZOLINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICION FARMACEUTICA - Google Patents
DERIVADO DE PIRAZOLINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICION FARMACEUTICAInfo
- Publication number
- AR018402A1 AR018402A1 ARP990102513A ARP990102513A AR018402A1 AR 018402 A1 AR018402 A1 AR 018402A1 AR P990102513 A ARP990102513 A AR P990102513A AR P990102513 A ARP990102513 A AR P990102513A AR 018402 A1 AR018402 A1 AR 018402A1
- Authority
- AR
- Argentina
- Prior art keywords
- atom
- general formula
- methyl group
- pharmaceutical composition
- trifluoromethyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000004429 atom Chemical group 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 102000010907 Cyclooxygenase 2 Human genes 0.000 abstract 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 125000002843 carboxylic acid group Chemical group 0.000 abstract 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract 1
- 231100000417 nephrotoxicity Toxicity 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 abstract 1
- 229940067157 phenylhydrazine Drugs 0.000 abstract 1
- DNXIASIHZYFFRO-UHFFFAOYSA-N pyrazoline Chemical compound C1CN=NC1 DNXIASIHZYFFRO-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES009801129A ES2137138B1 (es) | 1998-05-29 | 1998-05-29 | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018402A1 true AR018402A1 (es) | 2001-11-14 |
Family
ID=8303969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990102513A AR018402A1 (es) | 1998-05-29 | 1999-05-27 | DERIVADO DE PIRAZOLINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICION FARMACEUTICA |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6353117B1 (enExample) |
| EP (1) | EP1083171B1 (enExample) |
| JP (1) | JP4633928B2 (enExample) |
| KR (1) | KR100603666B1 (enExample) |
| CN (1) | CN1189459C (enExample) |
| AR (1) | AR018402A1 (enExample) |
| AT (1) | ATE265437T1 (enExample) |
| AU (1) | AU752001B2 (enExample) |
| BG (1) | BG64950B1 (enExample) |
| BR (1) | BR9910801A (enExample) |
| CA (1) | CA2333475C (enExample) |
| CO (1) | CO5031241A1 (enExample) |
| CU (1) | CU22995A3 (enExample) |
| CZ (1) | CZ298391B6 (enExample) |
| DE (1) | DE69916828T2 (enExample) |
| DK (1) | DK1083171T3 (enExample) |
| ES (2) | ES2137138B1 (enExample) |
| GE (1) | GEP20043237B (enExample) |
| HU (1) | HUP0102102A3 (enExample) |
| IS (1) | IS2040B (enExample) |
| LT (1) | LT4879B (enExample) |
| LV (1) | LV12632B (enExample) |
| NO (1) | NO316600B1 (enExample) |
| NZ (1) | NZ508990A (enExample) |
| PL (1) | PL344412A1 (enExample) |
| PT (1) | PT1083171E (enExample) |
| RU (1) | RU2233272C2 (enExample) |
| SI (1) | SI20580B (enExample) |
| SK (1) | SK285550B6 (enExample) |
| TW (1) | TW572898B (enExample) |
| WO (1) | WO1999062884A1 (enExample) |
| ZA (1) | ZA200007638B (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ516553A (en) | 1999-06-16 | 2004-01-30 | Univ Temple | 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 and its preparation method |
| DE60016191T2 (de) | 1999-12-08 | 2005-12-22 | Pharmacia Corp., Chicago | Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt |
| ES2174757B1 (es) * | 2001-04-06 | 2003-11-01 | Esteve Labor Dr | Empleo de derivados de firazolinas en la elaboracion de un medicamentopara la prevencion y/o el tratamiento de enfermedades proliferativas celulares. |
| US20030105144A1 (en) | 2001-04-17 | 2003-06-05 | Ping Gao | Stabilized oral pharmaceutical composition |
| US6878729B2 (en) | 2001-05-04 | 2005-04-12 | The Procter & Gamble Company | Medicinal uses of dihydropyrazoles |
| ES2183720B1 (es) | 2001-06-18 | 2004-01-16 | Esteve Labor Dr | Procedimiento para la preparacion de derivados de 1,5-diaril-3-trifluorometil-delta2-pirazolinas racemicas y enantiomericamente puras. |
| WO2004098619A2 (en) | 2003-05-07 | 2004-11-18 | Osteologix A/S | Treating cartilage / bone conditions with water-soluble strontium salts |
| ES2238923B1 (es) * | 2004-02-16 | 2006-11-01 | Laboratorios Del Dr. Esteve, S.A. | Nuevos derivados pirazolinicos sustituidos. |
| US7998996B2 (en) * | 2004-02-17 | 2011-08-16 | Laboratorios Del Dr. Esteve S.A. | Substituted pyrazoline compounds for reducing triglycerides in blood |
| ES2257929B1 (es) * | 2004-07-16 | 2007-05-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de pirazolina, procedimiento para su obtencion y utilizacion de los mismos como agentes terapeuticos. |
| ES2278503B1 (es) * | 2005-06-27 | 2008-06-16 | Laboratorios Del Dr. Esteve, S.A. | Epoxidacion de cetonas alfa, beta - insaturadas. |
| WO2007009710A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds: methods for their preparation |
| ES2336883B1 (es) * | 2005-07-15 | 2011-03-22 | Laboratorios Del Dr. Esteve, S.A. | Compuestos de pirazolina sustituidos, con una estereoquimica predeterminada, para la reduccion de trigliceridos en sangre. |
| EP1743636A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Combination of a substituted pyrazoline compound and a drug used in food-related disorders |
| WO2007009703A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | New formulations of substituted pyrazoline compounds |
| ES2330716B1 (es) * | 2005-07-15 | 2010-07-09 | Laboratorios Del Dr.Esteve, S.A. | Formulaciones farmaceuticas de compuestos de pirazolina sustituidos. |
| EP1743643A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | New formulations of substituted pyrazoline compounds |
| EP1743642A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases |
| WO2007009698A1 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A | Combination of pyrazoline type cannabinoid receptor antagonist and statin |
| EP1745781A1 (en) * | 2005-07-15 | 2007-01-24 | Laboratorios Del Dr. Esteve, S.A. | Combination of pyrazoline type cannabinoid receptor antagonist and statin |
| EP1749526A1 (en) * | 2005-07-15 | 2007-02-07 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| EP1743638A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Pharmaceutical formulations of substituted pyrazoline compounds |
| ES2326725B1 (es) * | 2005-07-15 | 2010-05-11 | Laboratorios Del Dr. Esteve, S.A. | Uso de compuestos de pirazolina sustituidos para el tratamiento de trastornos alimentarios, que incluyen la obesidad o el sindrome metabolico en pacientes con diabetes desarrollada. |
| ES2316306B1 (es) * | 2005-07-15 | 2009-11-23 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de un compuesto de pirazolina sustituido y un farmaco utilizado en trastornos relacionados con los alimentos. |
| WO2007009692A1 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A | Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| EP1849784A1 (en) * | 2006-04-26 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Indoline-substituted pyrazoline compounds, their preparation and use as medicaments |
| EP1743892A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios del Dr. Esteve S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
| EP1760078A1 (en) * | 2005-07-15 | 2007-03-07 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds; methods for their preparation |
| WO2007009699A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A | Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases |
| EP1757587A1 (en) * | 2005-07-15 | 2007-02-28 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
| WO2007009706A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| AR061623A1 (es) * | 2006-06-26 | 2008-09-10 | Novartis Ag | Derivados de acido fenilacetico |
| US20100111858A1 (en) * | 2007-01-19 | 2010-05-06 | Howard Carol P | Diangostic and Therapeutic Cyclooxygenase-2 Binding Ligands |
| EP3009137A1 (en) * | 2014-10-16 | 2016-04-20 | Ecuphar N.V. | Pyrazoline-derived compound and its use in a weekly dosage regime against inflammation and pain derived from degenerative joint disease in mammals |
| EP4029502A1 (en) | 2021-01-15 | 2022-07-20 | Ecuphar N.V. | Pyrazoline-derived compound (enflicoxib) for use in the prevention and/or treatment of pain and inflammation associated to surgery in mammals |
| CA3209491A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
| US12208085B2 (en) | 2022-05-31 | 2025-01-28 | Ecuphar Nv | Pyrazoline-derived compound for use in the prevention and/or treatment of pain and inflammation associated to surgery in mammals |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2060660B (en) * | 1979-10-18 | 1983-11-23 | Bostik Ltd | Adhesives containing pyrazoline activators |
| JPS5818363A (ja) * | 1981-07-13 | 1983-02-02 | アメリカン・サイアナミド・カンパニ− | 複素環式置換アミノピラゾリン類およびその薬としての用途 |
| AU598633B2 (en) * | 1987-01-05 | 1990-06-28 | E.I. Du Pont De Nemours And Company | 1-sub-phenyl-3-sub-phenylamino(thio) carbonyl-pyrazolines as insecticides |
| PH27357A (en) * | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| AU708964B2 (en) * | 1995-05-25 | 1999-08-19 | G.D. Searle & Co. | Method of preparing 3-haloalkyl-1h-pyrazoles |
| GB9520584D0 (en) * | 1995-10-09 | 1995-12-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
-
1998
- 1998-05-29 ES ES009801129A patent/ES2137138B1/es not_active Expired - Lifetime
-
1999
- 1999-05-27 CA CA002333475A patent/CA2333475C/en not_active Expired - Lifetime
- 1999-05-27 AR ARP990102513A patent/AR018402A1/es active IP Right Grant
- 1999-05-27 SK SK1807-2000A patent/SK285550B6/sk unknown
- 1999-05-27 AT AT99922192T patent/ATE265437T1/de active
- 1999-05-27 CZ CZ20004418A patent/CZ298391B6/cs not_active IP Right Cessation
- 1999-05-27 PL PL99344412A patent/PL344412A1/xx not_active IP Right Cessation
- 1999-05-27 HU HU0102102A patent/HUP0102102A3/hu unknown
- 1999-05-27 GE GEAP19995706A patent/GEP20043237B/en unknown
- 1999-05-27 CO CO99032824A patent/CO5031241A1/es unknown
- 1999-05-27 EP EP99922192A patent/EP1083171B1/en not_active Expired - Lifetime
- 1999-05-27 BR BR9910801-1A patent/BR9910801A/pt not_active Application Discontinuation
- 1999-05-27 PT PT99922192T patent/PT1083171E/pt unknown
- 1999-05-27 US US09/701,276 patent/US6353117B1/en not_active Ceased
- 1999-05-27 AU AU39329/99A patent/AU752001B2/en not_active Ceased
- 1999-05-27 US US10/229,880 patent/USRE38963E1/en not_active Expired - Lifetime
- 1999-05-27 TW TW88108709A patent/TW572898B/zh not_active IP Right Cessation
- 1999-05-27 KR KR1020007013447A patent/KR100603666B1/ko not_active Expired - Fee Related
- 1999-05-27 NZ NZ508990A patent/NZ508990A/xx unknown
- 1999-05-27 SI SI9920042A patent/SI20580B/sl not_active IP Right Cessation
- 1999-05-27 CN CNB998081116A patent/CN1189459C/zh not_active Expired - Lifetime
- 1999-05-27 DK DK99922192T patent/DK1083171T3/da active
- 1999-05-27 DE DE69916828T patent/DE69916828T2/de not_active Expired - Lifetime
- 1999-05-27 ES ES99922192T patent/ES2221382T3/es not_active Expired - Lifetime
- 1999-05-27 JP JP2000552096A patent/JP4633928B2/ja not_active Expired - Lifetime
- 1999-05-27 WO PCT/ES1999/000156 patent/WO1999062884A1/es not_active Ceased
- 1999-05-27 RU RU2000133231/04A patent/RU2233272C2/ru not_active IP Right Cessation
-
2000
- 2000-11-28 IS IS5736A patent/IS2040B/is unknown
- 2000-11-28 LT LT2000108A patent/LT4879B/lt not_active IP Right Cessation
- 2000-11-28 NO NO20006029A patent/NO316600B1/no not_active Application Discontinuation
- 2000-11-29 BG BG105005A patent/BG64950B1/bg unknown
- 2000-12-19 ZA ZA200007638A patent/ZA200007638B/xx unknown
- 2000-12-27 CU CU20000307A patent/CU22995A3/es unknown
- 2000-12-28 LV LVP-00-161A patent/LV12632B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR018402A1 (es) | DERIVADO DE PIRAZOLINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICION FARMACEUTICA | |
| US6803380B1 (en) | 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them | |
| NO943165L (no) | Heterocykliske karbonsyrederivater som binder til retinoid-reseptorer (RAR) | |
| DK0778834T3 (da) | Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2 | |
| ATE208397T1 (de) | Arylsubstituierte 5,5 verknüpfte aromatische nitroverbindungen als entzündungshemmende wirkstoffe | |
| MY140057A (en) | Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
| LU91145I2 (fr) | FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX). | |
| UA74391C2 (uk) | Арил- або гетероарилконденсовані імідазоли як антизапальні і анальгетичні агенти | |
| YU54902A (sh) | Nova jedinjenja koja ispoljavaju hipolipidemijsku i hipoholesterolemijsku aktivnost, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže | |
| TW460470B (en) | 3,4-diaryloxazolone derivatives, their methods of preparation and their uses in therapeutics | |
| BR9507231A (pt) | Uso de derivados de ácido carboxílico para a produção de drogas | |
| TW520365B (en) | Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, their methods of preparation and their uses in therapeutics | |
| MX2024014315A (es) | Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas | |
| SE8700714D0 (sv) | Anvendning av substituerade 4-fenyl-4-oxo-2-butensyraderivat for framstellning av lekemedel for behandling av sjukdomar i matsmeltningskanalen och som antiulcerost lekemedel | |
| HUP0202692A2 (hu) | Interleukin-5 inhibitor hatású 6-azauracil-származékok, ezeket tartalmazó gyógyszerkészítmények és intermedierjeik | |
| NO305595B1 (no) | Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer, farmas°ytisk preparat og anvendelse derav | |
| DK0678088T3 (da) | N-acylpyrrolidiner og lægemidler til behandling og forebyggelse af cholecystokinin- og gastrinrelaterede sygdomme | |
| AR026241A1 (es) | Empleo de carbinoles 2-imidazolil substituidos para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas porestados isquemicos | |
| ES531318A0 (es) | Procedimiento para la obtencion de derivados quinolinicos | |
| JPH0454160A (ja) | テトラサイクリン誘導体 | |
| ES2142350T3 (es) | Amidas del acido 4-oxo-acetidin-2-sulfonico y sus sales, procedimiento para su preparacion y su utilizacion. | |
| SE8500963L (sv) | Nitroaminodiarylsulfoxidderivat, forfarande for deras framstellning och farmaceutiska och pesticidiska kompositioner innehallande desamma | |
| PT1299350E (pt) | Benzamidas substituidas para o aumento de imunidade e para o tratamento do cancro, infeccoes e da doenca manioco-depressiva |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |